CardioMed Device Consultants, LLC
6
0
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
2 terminated/withdrawn out of 6 trials
60.0%
-26.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
Role: collaborator
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Role: collaborator
A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population
Role: collaborator
A Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population
Role: collaborator
The Angel® Catheter Pivotal Clinical Trial
Role: collaborator
A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population
Role: collaborator
All 6 trials loaded